Is Calcitonin-salmon legal in the US?
Yes, FDA approved for Paget's disease of bone, high blood calcium and bone loss after menopause.
Calcitonin-salmon is FDA-approved. The injection (Miacalcin) is labeled for Paget's disease of bone, hypercalcemia and postmenopausal osteoporosis; the nasal spray, now sold as a generic, is labeled only for postmenopausal osteoporosis in women more than five years past menopause when alternatives are not suitable. 56
Yes. The injection is approved for Paget's disease, hypercalcemia and postmenopausal osteoporosis. The nasal spray is approved only for postmenopausal osteoporosis. That means women more than five years past menopause who cannot use other treatments. 56
Read the full Calcitonin-salmon page
More on Calcitonin-salmon
Citations
- Drugs.com AHFS monograph: calcitonin-salmon drugs.com
- DrugBank DB00017: salmon calcitonin go.drugbank.com
- Chesnut 2000, Am J Med: randomized trial of nasal spray salmon calcitonin in postmenopausal osteoporosis (PROOF) doi.org
- EMA referral, 2012: calcitonin-containing medicines ema.europa.eu
- Miacalcin injection prescribing information drugs.com
- Miacalcin nasal spray prescribing information drugs.com
Reference information only, not medical advice. Drawn from the Calcitonin-salmon article, fact-checked against the cited sources. No dosing anywhere on this site.